BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12669857)

  • 1. Probing DNA selectivity of ruthenium metallointercalators using ESI mass spectrometry.
    Beck JL; Gupta R; Urathamakul T; Williamson NL; Sheil MM; Aldrich-Wright JR; Ralph SF
    Chem Commun (Camb); 2003 Mar; (5):626-7. PubMed ID: 12669857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2D NMR spectroscopic evidence for unprecedented interactions of cis-[Rh2(dap)(mu-O2CCH3)2(eta1-O2CCH3)(CH3OH)](O2CCH3) with a DNA oligonucleotide: combination of intercalative and coordinative binding.
    Kang M; Chouai A; Chifotides HT; Dunbar KR
    Angew Chem Int Ed Engl; 2006 Sep; 45(37):6148-51. PubMed ID: 16927356
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of mass spectrometry and other techniques for probing interactions between metal complexes and DNA.
    Urathamakul T; Waller DJ; Beck JL; Aldrich-Wright JR; Ralph SF
    Inorg Chem; 2008 Aug; 47(15):6621-32. PubMed ID: 18611003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction studies of DNA binding of ruthenium(II) mixed-ligand complexes: [Ru(phen)2(dtmi)]2+ and [Ru(phen)2(dtni)]2+.
    Liu YJ; Wei XY; Wu FH; Mei WJ; He LX
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):171-6. PubMed ID: 17825604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of quenching by [Fe(CN)6]4- is not proof of DNA intercalation.
    Burya SJ; Lutterman DA; Turro C
    Chem Commun (Camb); 2011 Feb; 47(6):1848-50. PubMed ID: 21206938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex.
    Wu K; Luo Q; Hu W; Li X; Wang F; Xiong S; Sadler PJ
    Metallomics; 2012 Feb; 4(2):139-48. PubMed ID: 22262368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions with DNA: Into the minor groove.
    Neidle S
    Nat Chem; 2012 Jul; 4(8):594-5. PubMed ID: 22824886
    [No Abstract]   [Full Text] [Related]  

  • 8. A mass spectrometric investigation of non-covalent interactions between ruthenium complexes and DNA.
    Urathamakul T; Beck JL; Sheil MM; Aldrich-Wright JR; Ralph SF
    Dalton Trans; 2004 Sep; (17):2683-90. PubMed ID: 15514752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design of new molecular "light switches" for DNA.
    Zou XH; Ye BH; Li H; Zhang QL; Chao H; Liu JG; Ji LN; Li XY
    J Biol Inorg Chem; 2001 Feb; 6(2):143-50. PubMed ID: 11293407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoactive Ru(II) -polypyridyl complexes that display sequence selectivity and high-affinity binding to duplex DNA through groove binding.
    Ghosh A; Das P; Gill MR; Kar P; Walker MG; Thomas JA; Das A
    Chemistry; 2011 Feb; 17(7):2089-98. PubMed ID: 21254265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of dipyridophenazine complexes of ruthenium(II): the light switch effect as a function of nucleic acid sequence and conformation.
    Jenkins Y; Friedman AE; Turro NJ; Barton JK
    Biochemistry; 1992 Nov; 31(44):10809-16. PubMed ID: 1420195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA and RNA specificity of eilatin Ru(II) complexes as compared to eilatin and ethidium bromide.
    Luedtke NW; Hwang JS; Nava E; Gut D; Kol M; Tor Y
    Nucleic Acids Res; 2003 Oct; 31(19):5732-40. PubMed ID: 14500837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstrand DNA covalent binding of two dinuclear Ru(ii) complexes. Influence of the extra ring of the bridging ligand on the DNA interaction and cytotoxic activity.
    Lozano HJ; Busto N; Espino G; Carbayo A; Leal JM; Platts JA; GarcĂ­a B
    Dalton Trans; 2017 Mar; 46(11):3611-3622. PubMed ID: 28243638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity at a three-base bulge site in the DNA binding of DeltaDelta-[{Ru(phen)2} 2(mu-dppm)]4+ [dppm is 4,6-bis(2-pyridyl)pyrimidine; phen is 1,10-phenanthroline].
    Morgan JL; Buck DP; Turley AG; Collins JG; Keene FR
    J Biol Inorg Chem; 2006 Oct; 11(7):824-34. PubMed ID: 16804676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT-dependent luminescence of DNA-threading ruthenium complexes.
    Westerlund F; Lincoln P
    Biophys Chem; 2007 Aug; 129(1):11-7. PubMed ID: 17531370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry.
    Groessl M; Tsybin YO; Hartinger CG; Keppler BK; Dyson PJ
    J Biol Inorg Chem; 2010 Jun; 15(5):677-88. PubMed ID: 20213306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuning the DNA reactivity of cis-platinum: conjugation to a mismatch-specific metallointercalator.
    Petitjean A; Barton JK
    J Am Chem Soc; 2004 Nov; 126(45):14728-9. PubMed ID: 15535691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the binding of metal complexes to duplex and quadruplex DNA.
    Talib J; Green C; Davis KJ; Urathamakul T; Beck JL; Aldrich-Wright JR; Ralph SF
    Dalton Trans; 2008 Feb; (8):1018-26. PubMed ID: 18274682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive binding sites of a ruthenium arene anticancer complex on oligonucleotides studied by mass spectrometry: ladder-sequencing versus top-down.
    Wu K; Hu W; Luo Q; Li X; Xiong S; Sadler PJ; Wang F
    J Am Soc Mass Spectrom; 2013 Mar; 24(3):410-20. PubMed ID: 23404464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Characterization and Luminescence Sensitivity with Variance in pH, DNA and BSA Binding Studies of Ru(II) Polypyridyl Complexes.
    Vuradi RK; Avudoddi S; Putta VR; Kotha LR; Yata PK; Sirasani S
    J Fluoresc; 2017 May; 27(3):939-952. PubMed ID: 28160119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.